Deep Track Capital, LP Bicycle Therapeutics PLC Transaction History
Deep Track Capital, LP
- $3.03 Billion
- Q1 2024
A detailed history of Deep Track Capital, LP transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Deep Track Capital, LP holds 3,490,506 shares of BCYC stock, worth $70.6 Million. This represents 2.87% of its overall portfolio holdings.
Number of Shares
3,490,506
Previous 3,490,506
-0.0%
Holding current value
$70.6 Million
Previous $63.1 Million
37.72%
% of portfolio
2.87%
Previous 2.4%
Shares
5 transactions
Others Institutions Holding BCYC
# of Institutions
99Shares Held
30.6MCall Options Held
85.5KPut Options Held
11.6K-
Baker Bros. Advisors LP New York, NY4.94MShares$100 Million1.56% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.25MShares$65.7 Million3.03% of portfolio
-
Armistice Capital, LLC New York, NY1.67MShares$33.8 Million0.57% of portfolio
-
Tybourne Capital Management (Hk) LTD Hong Kong, K31.55MShares$31.3 Million8.61% of portfolio
-
Morgan Stanley New York, NY1.52MShares$30.7 Million0.0% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $601M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...